Skip to main content

Table 1 Clinical characteristics of the patients

From: The study of the association between immune monitoring and pneumonia in kidney transplant recipients through machine learning models

Characteristics

All (n = 146)

Pneumonia (n = 46)

Stable (n = 100)

P value

Age, years ± SD

40.61 ± 10.04

41.52 ± 8.01

40.19 ± 10.57

0.458

Male, n (%)

83 (56.8)

27 (58.7)

56 (56.0)

0.760

Donor, n (%)

0.098*

 DCD

144 (98.6)

44 (95.7)

100 (100)

 

 Relative

2 (1.4)

2 (4.3)

0 (0)

 

Time since transplant (months)

11.67 ± 11.15

14.67 ± 15.24

10.33 ± 8.47

0.732#

Induction, n (%)

 < 0.001*

 None

17 (11.6)

5 (10.9)

12 (12.0)

 

 ATG

106 (72.6)

22 (47.8)

84 (84.0)

 

 Basiliximab

7 (4.8)

3 (6.5)

4 (4.0)

 

 NA

16 (11.0)

16 (34.8)

0 (0)

 

eGFR (ml/min/1.73 m2)

71.31 ± 23.93

59.11 ± 24.62

76.92 ± 21.50

 < 0.001

CNI, n (%)

0.742*

 FK506

135 (92.5)

42 (91.3)

93 (93.0)

 

 CsA

11 (7.5)

4 (8.7)

7 (7.0)

 
  1. Estimated glomerular filtration rate (eGFR) calculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
  2. SD standard deviation, DCD donation after citizens' death, ATG anti-thymocyte globulin, NA not available, CNI calcineurin inhibitor, CsA cyclosporine A
  3. * Tested by Fisher’s exact test; # Tested by Mann–Whitney U test